Share: Facebook Twitter LinkedIn
Activity Provided By:


MPS II Research Highlights From the WORLDSymposium (Mucopolysaccharidosis type II; MPS II; Hunter syndrome)

Access Activity

Overview / Abstract:

This accredited CME activity, led by Barbara Burton, MD, Professor of Pediatrics at Northwestern University Feinberg School of Medicine, highlights the latest research about Mucopolysaccharidosis type II (MPS II; Hunter syndrome) presented at WORLDSymposium 2022 and provides expert analysis of its clinical relevance for busy members of the care team to help them care for patients they may encounter with this rare condition. MPS II, also known as Hunter syndrome, is a rare, progressive lysosomal disease caused by deficient activity of iduronate-2-sulfatase, attributable to pathogenic variants of the iduronate-2-sulfatase gene (IDS). Course facial features and skeletal irregularities are the dominant symptoms of the periphery but of great concern is the central symptoms (cognitive decline, seizures) that occur in the more severe cases.

Current treatment options are limited to improving peripheral but not central aspects of this disease and numerous therapies are in development to address the central symptoms that afflict patients with severe MPS II. Data about those therapies were presented at WORLDSymposium 2022 and discussed by Dr. Burton.


Apr 15, 2023


Nurse Practitioner , Physician CME, Physician Assistant CME


Webinar / Webcast / Video

Credits / Hours



American Academy of CME

Presenters / Authors / Faculty

Barbara Burton, MD
Professor of Medicine Professor of Pediatrics
Northwestern University Feinberg School of Medicine
Ann & Robert H. Lurie Children’s Hospital, Chicago

Activity Specialities / Related Topics

Genetics, Internal Medicine, Neurology, Ophthalmology / Optometry, Orthopedics, Pediatrics, Primary Care

Sponsors / Supporters / Grant Providers

Takeda Pharmaceuticals U.S.A. Inc.

Keywords / Search Terms

CheckRare rare disease, genetic disease, Mucopolysaccharidosis type II, MPS II, Hunter syndrome, rare disorder, Barbara Burton MD, Northwestern University Feinberg School of Medicine,WORLDSymposium, Lysosomal storage disease, lysosomal, Free CE CME

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map